Hansa Biopharma presenting at Jefferies Global Healthcare Conference and DNB Carnegie’s 16th Annual Nordic Healthcare Conference

Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA), today announced that Renée Aguiar-Lucander, CEO, Hansa Biopharma, will be participating in a fireside chat with Farzin Haque, Biotechnology Equity Research Analyst, Jefferies, at the Jefferies Healthcare Conference in London, on Monday 17 November, 2025. Aguiar-Lucander will also present Hansa Biopharma at DNB Carnegie’s 16 th Annual Nordic Healthcare Conference in Oslo, Tuesday 25 November, 2025.